World Well being IPO Date, Worth Band, Percentage Allotment Date, Record Date: World Well being Restricted‘s preliminary public providing (IPO) will open on Thursday, November 3, for subscriptions. The preliminary percentage sale will stay open for subscription until November 7. World Well being operates and manages hospitals underneath the Medanta emblem. It has fastened a value band of Rs 319-336 a percentage for its Rs 2,206 crore IPO.
The IPO incorporates contemporary issuance of fairness stocks value Rs 500 crore and an be offering of sale as much as 5.08 crore fairness stocks through promoters and present shareholders. The face price of every percentage could be Rs 2. On the higher finish of the fee band, the corporate is anticipated to fetch Rs 2,206 crore in the course of the IPO.
Part of the problem dimension has been reserved for certified institutional buyers, 35 in step with cent for retail buyers and the rest 15 in step with cent for non-institutional buyers. Traders can bid for at least 44 stocks and in multiples thereof.
World Well being IPO allotment date
World Well being IPO allocated date is November 11.
World Well being IPO checklist date
World Well being IPO will checklist on each the main exchanges BSE and NSE. World Well being IPO checklist date most likely is November 16.
Executive of Singapore, Nomura, Axis Mutual Fund (MF), HDFC MF, Aditya Birla Solar Lifestyles MF, SBI MF, ICICI Prudential MF, Kotak MF, Max Lifestyles Insurance coverage Corporate and SBI Lifestyles
Insurance coverage Corporate are some of the anchor buyers.
Forward of the IPO, World Well being has mobilised Rs 662 crore from anchor buyers that open for public subscription on Thursday. The corporate has determined to allocate 1.97 crore fairness stocks at Rs 336 apiece, aggregating the transaction dimension to about Rs 662 crore, consistent with a round uploaded at the BSE website online.
Based through Dr Naresh Trehan, a famend cardiovascular and cardiothoracic surgeon, World Well being is a number one non-public multi-specialty tertiary care supplier within the north and east areas of India.
The corporate intends to capitalise on clinical tourism, as a part of its enlargement methods.
The corporate delivered a complete source of revenue of Rs 2,205.8 crore and a benefit of Rs 196.2 crore in FY22.
(with PTI inputs)